Cullinan Therapeutics to participate in Stifel 2026 immunology forum
Cullinan Therapeutics (Nasdaq: CGEM) said it will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
CGEM - Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
CGEM - Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum